Complete Wegovy vs Mounjaro Dose Guide With UK's Best Prices
Wegovy Dose vs Mounjaro Dose: UK's Lowest Price Advantage
When comparing Wegovy dose vs Mounjaro dose options, pricing plays a crucial role in your long-term weight management strategy. EverydayMeds offers the UK's most competitive rates for both treatments, with Wegovy starting at £79.99 for the 0.25mg starter dose and comprehensive bundle options available. Our transparent pricing includes clinical assessment, prescriber review, and next-day delivery—no hidden costs or subscription traps that other providers use.
The Wegovy dose vs Mounjaro dose comparison reveals different escalation timelines affecting your monthly costs. Wegovy follows a 5-stage dose escalation over 16 weeks (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) whilst Mounjaro uses 4 stages over 12 weeks (2.5mg, 5mg, 10mg, 15mg). Both are prescription-only medicines requiring proper clinical oversight, which EverydayMeds provides through our GPhC-registered pharmacy (#9012878) with qualified prescribers reviewing every assessment.
Detailed Pricing Breakdown: Wegovy Dose vs Mounjaro Dose Costs
Our Wegovy pricing structure reflects each dose stage: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and maintenance 2.4mg (£209.99). New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive rates. Bundle options like our Intro Trio (0.25mg, 0.5mg, 1mg) at £299.99 provide convenience for the initial escalation phase without frequent reordering.
When evaluating Wegovy dose vs Mounjaro dose costs, consider the different maintenance phases. Wegovy reaches its maintenance dose (2.4mg) at week 17, requiring one pen monthly thereafter. Mounjaro typically reaches maintenance (10mg or 15mg) by week 12, with similar monthly requirements. Both treatments require ongoing use for sustained weight management, as clinical studies show weight regain when discontinued—making our competitive pricing essential for long-term success.
Clinical Evidence: Wegovy Dose vs Mounjaro Dose Efficacy
In the STEP clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). The dose escalation protocol used in these studies mirrors our prescribing approach, starting with 0.25mg and progressing to 2.4mg maintenance. Individual results may vary, and weight management requires long-term commitment alongside reduced-calorie diet and increased physical activity.
When comparing Wegovy dose vs Mounjaro dose clinical data, both medications demonstrated significant weight management benefits in their respective trials. However, these studies used different populations, endpoints, and methodologies, making direct comparisons inappropriate. Both treatments are MHRA-approved for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities, requiring proper clinical assessment before initiation.
How Wegovy Works: Understanding the Dose Escalation Process
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones in your body. The medication works on brain appetite centres, reducing hunger signals and promoting satiety after smaller meals. This mechanism explains why the Wegovy dose vs Mounjaro dose comparison matters—each treatment targets slightly different pathways (Wegovy targets GLP-1 only, whilst Mounjaro targets both GIP and GLP-1 receptors). The gradual dose escalation allows your body to adjust to these hormonal changes, minimising potential side effects whilst building therapeutic efficacy. Starting at 0.25mg and increasing every four weeks helps establish tolerance before reaching the full 2.4mg maintenance dose that provides optimal weight management support.
Streamlined Ordering Process for Both Wegovy and Mounjaro
Our clinical assessment takes just three minutes online, covering medical history, current medications, and weight management goals relevant to both treatments. Qualified prescribers review every application, typically within three working days (24-hour express option available), ensuring appropriate medication selection whether you choose Wegovy or Mounjaro. Once approved, your medication ships via next-day delivery in temperature-controlled packaging, maintaining the cold-chain requirements essential for both treatments. Our process includes detailed dosing instructions, injection technique guidance, and ongoing support throughout your treatment journey. The entire system operates through our GPhC-registered pharmacy (#9012878), ensuring full regulatory compliance and patient safety standards.
Storage and Practical Considerations: Wegovy Dose vs Mounjaro Dose
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable for 6 weeks at room temperature (below 30°C) once removed from the fridge, versus Mounjaro's 21-day limit. Both medications require initial refrigeration at 2-8°C, but Wegovy's extended room temperature stability provides travel convenience and reduces wastage from temperature excursions. The FlexTouch pen delivery system is identical for all Wegovy doses, ensuring consistent injection experience throughout your escalation journey from 0.25mg to 2.4mg. Each pen contains four weekly doses, eliminating the complexity of multi-dose vials or reconstitution requirements. The dose escalation cannot be skipped or accelerated—this graduated approach is essential for both safety and efficacy, as demonstrated in clinical trials.
Wegovy Dose vs Mounjaro Dose: Value Beyond Initial Cost
The true value proposition when comparing Wegovy dose vs Mounjaro dose extends beyond unit pricing to include success rates, storage convenience, and long-term maintenance requirements. Wegovy's proven track record in the STEP trials, combined with its superior storage stability, may offer better value for patients who travel frequently or live in areas with temperature fluctuations. Our bundle pricing reflects this long-term perspective, providing convenient supply options that ensure treatment continuity without frequent reordering.
Cost-effectiveness analysis of Wegovy dose vs Mounjaro dose should include the different escalation timelines and maintenance dosing patterns. Wegovy's 16-week escalation period may seem longer than Mounjaro's 12 weeks, but this gradual approach often results in better tolerance and treatment persistence. Studies suggest that patients who complete the full dose escalation successfully are more likely to maintain long-term treatment, making the initial investment in proper dosing particularly valuable for sustained weight management outcomes.
Expert Clinical Support and Best-competitive pricing
EverydayMeds combines the UK's lowest pricing with clinical excellence, ensuring your Wegovy dose vs Mounjaro dose decision receives proper medical oversight. Our qualified prescribers evaluate each case individually, considering medical history, previous weight management attempts, and personal circumstances that might favour one treatment over another. New customers can access these services using code FIRST40, whilst returning customers apply DOSE25 for continued competitive pricing. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and join thousands of patients achieving their weight management goals with proper medical support. Our commitment to providing both treatments at the UK's best prices, combined with clinical excellence and convenient delivery, makes EverydayMeds your trusted partner for prescription-only weight management medications.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
